Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

OBJECTIVE: Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L
Format: Journal article
Sprog:English
Udgivet: 2012

Lignende værker